How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Four top Google AI researchers, including Sanjay Ghemawat, launch Discovery Loop to accelerate scientific research through advanced AI ...

May 15, 2025 A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ...

Introduction Every ambitious Creative build eventually reaches the same calculation. A castle wall that is forty blocks long, ...